This app is for sale. Asking price: $24,340
2.2x revenue
338 buyers have viewed this
2 offers made
Shotwise app icon

Shotwise

Wegovy, Ozempic, Mounjaro

Take control of your GLP-1 treatment journey with Shotwise, the ultimate companion app designed to simplify injection tracking and monitor your progress effortlessly. Shotwise helps you stay consistent, informed, and motivated.

Worldwide Release Date: January 9, 2025

Verified withRevenueCatFor Sale
#150 MRR
#196 Revenue
#48 in Health & Fitness
Transparency: 10/10

Star Ratings(129 ratings | avg ★ 4.6)

App Store (129 ratings)

us

4.7

106 ratings

gb

4.5

14 ratings

ca

5.0

4 ratings

nl

2.5

2 ratings

fr

5.0

1 rating

de

3.0

1 rating

br

5.0

1 rating

Total Downloads (Android)

100+

Last 28 days

Revenue

$935

AR

$11,220

MRR

$1,217

ARR

$14,604

Cash Flow Index

0.8x

Active Subscriptions

768

Active Trials

3

ARPAS

$1.21

Paid Subscriber Share (snapshot)

99.6%

Active Customers

661

New Customers

200

Subscription Penetration

116.2%

ARPU

$1.41

RPD

$1.41

ARPPU

$1.58

LTV

$14

MRR Growth (28d)

-12.4%

Subscriber Growth (28d)

-11.3%

All data is verified through RevenueCat. Last updated: Jul 27, 2026, 10:31:39 AM UTC.

App Screenshots

Shotwise screenshot 1
Shotwise screenshot 2
Shotwise screenshot 3
Shotwise screenshot 4
Shotwise screenshot 5

In-App Pricing

ShotWise Pro Annual$24.99
ShotWise Pro Annual$9.99
Shotwise Pro Annual$4.99

Tech Stack

Frontend
ExpoExpo

About This Listing

A GLP-1 shot tracker app, low maintenance, huge market and potential for improvement. Also potential for expanded revenue through GLP-1 affiliates that is a huge opportunity but one I haven’t had the time or bandwidth to explore.

Asking Price

$24,340

Sale Details

Business Operations Started

Jan 2025

Assets Included in Sale

Social media accounts

Source Code Included

Yes

Post-Sales Support

Yes, seller will provide support
Privacy Policy|Terms of Service